張?jiān)品?/p>

[關(guān)鍵詞] 神經(jīng)內(nèi)鏡;立體定向手術(shù);中少量高血壓腦出血;應(yīng)用價(jià)值

[中圖分類號(hào)] R743.34? ? ? ? ? [文獻(xiàn)標(biāo)識(shí)碼] B? ? ? ? ? [文章編號(hào)] 1673-9701（2021）25-0055-03

Experience of application value of neuroendoscopy and stereotactic surgery in treating moderate and small amount of hypertensive intracerebral hemorrhage

ZHANG Yunfeng

Department of Neurosurgery， Anqing Hospital of the PLA Navy， Anqing? ?246003， China

[Abstract] Objective To treat moderate and small amount of hypertensive intracerebral hemorrhage by neuroendoscopy and stereotactic surgery， and to compare and analyze the application value of neuroendoscopy and stereotactic surgery. Methods A total of 100 patients with moderate and small amount of hypertensive intracerebral hemorrhage were selected from December 2016 to December 2020， and were treated differently： the study group was treated with neuroendoscopy combined with small bone window surgery， while the control group was treated with stereotactic surgery. The SPSS 21.0 software was used to systematically analyze and compare the length of stay， treatment cost and quality of life scores between the two groups. Results According to analysis with the SPSS 21.0 software， the length of stay in the study group （15.22±2.33）d and treatment cost （1.32±0.33）ten thousands yuan were lower than those in the control group， and the quality of life score of the study group （89.22±2.33）points was higher than that of the control group （70.66±3.21）points， with statistically significant differences （P<0.05）. Conclusion The application value of neuroendoscopic surgery in the treatment of moderate and small amount of hypertensive intracerebral hemorrhage is significant， which can improve the quality of life of patients， shorten the length of hospital stay and reduce the treatment cost.

[Key words] Neuroendoscopy; Stereotactic surgery; Moderate and small amount of hypertensive intracerebral hemorrhage; Application value

高血壓腦出血指因情緒激動(dòng)、過(guò)度腦力與體力勞動(dòng)或其他因素引起血壓劇烈升高，導(dǎo)致腦血管破裂出血，致死致殘率較高。小骨窗開顱血腫清除術(shù)為治療高血壓腦出血的常用方法，其具有清除腦血腫的作用，且效果理想，副作用少，但對(duì)術(shù)者操作要求較高[1-3]。隨著微創(chuàng)技術(shù)的發(fā)展及內(nèi)鏡技術(shù)的發(fā)展，神經(jīng)內(nèi)鏡已成為治療腦出血的新方法，通過(guò)神經(jīng)內(nèi)鏡輔助技術(shù)可直觀地觀察止血并清除血腫，避免盲穿造成誤傷和無(wú)法直接止血等缺點(diǎn)。高血壓腦出血是一種十分常見的腦血管疾病，致殘率和死亡率均較高。立體定向手術(shù)、神經(jīng)內(nèi)鏡結(jié)合小骨窗術(shù)等方式均是目前治療高血壓腦出血的主要臨床應(yīng)用方法。本文對(duì)中少量高血壓腦出血予以神經(jīng)內(nèi)鏡與立體定向手術(shù)治療，對(duì)比分析神經(jīng)內(nèi)鏡與立體定向手術(shù)治療的應(yīng)用價(jià)值。

1 資料與方法

1.1 一般資料

選擇2016年12月至2020年12月中少量高血壓腦出血患者，患者100例，選擇時(shí)間于2016年12月—2020年12月，行不同的治療方式：神經(jīng)內(nèi)鏡結(jié)合小骨窗術(shù)治療、立體定向手術(shù)治療，對(duì)應(yīng)組別：研究組、對(duì)照組。每組各50例。

研究組：50例患者中有男30例、女20例;年齡40～60歲，平均年齡（50.09±5.11）歲;基底節(jié)出血、腦葉出血、丘腦出血和腦室出血的患者例數(shù)分別為15、13、12、10例。